This approach mirrors strategies used with other peptide therapies to optimize tolerability
"We have needed alternative drugs that work on new targets for a very long time, because patients who develop resistance" to existing drugs have few effective treatment options, study author Deepak Shukla, the Marion Schenk professor of ophthalmology and professor of microbiology and immunology at the UIC College of Medicine, said in a press release
Investigators also collected serial blood samples to track shifts in lipids, C-reactive protein, and liver enzymes, providing a broader picture of metabolic health
Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment
Considering that the peptide is an analog of insulin-like growth factor 1, athletes and bodybuilders use it in a similar fashion, mainly by injecting it subcutaneously once or twice a day